Oncology Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
NCT Number: NCT07097519
Intensive care unit (ICU) nurses often experience high levels of stress and anxiety due to the emotional demands of caring for critically ill patients. These psychological burdens can negatively affect their job performance and the quality of care they provide. Recent studies suggest that immersive virtual reality (IVR) technology may help reduce stress and improve professional performance among healthcare workers. However, no study to date has specifically evaluated the effects of IVR on ICU nurses' anxiety, stress, and job performance.
This study aims to evaluate whether an IVR application can reduce anxiety and stress levels while enhancing the job performance of ICU nurses. By introducing a clinical intervention based on virtual reality, the research seeks to explore its potential as a practical tool in improving nurses' well-being and work effectiveness in high-pressure environments. The findings will contribute to understanding the clinical applicability of IVR as a stress-reduction and performance-enhancement method in intensive care settings.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Ankara, Yenimahalle, Turkey (Türkiye)
This study investigates the impact of an immersive virtual reality (IVR) intervention on the anxiety, stress, and professional performance of registered nurses working in intensive care units (ICUs). ICU nurses frequently face emotionally demanding situations, including end-of-life care, which can lead to elevated stress and anxiety levels. These psychological challenges have been associated with decreased job performance and compromised quality of patient care.
Technological innovations, particularly in virtual reality, offer promising solutions for mental health support and professional development in healthcare. IVR has been used successfully in various healthcare settings to reduce stress, improve coping strategies, and enhance performance. Despite this, no study has yet specifically examined its effect on ICU nurses.
In this randomized controlled trial, participants will be assigned to either an intervention group using the IVR application or a control group receiving standard care. The IVR experience is designed to promote relaxation, reduce psychological strain, and reinforce professional competencies through immersive scenarios. Outcome measures will include validated scales for anxiety, stress, and job performance, collected before and after the intervention.
The ultimate goal of this study is to assess the clinical applicability of IVR technology in supporting ICU nurses' mental well-being and work performance, offering a novel approach to workforce resilience in critical care settings.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention involves the use of a high-end immersive virtual reality (IVR) application through the Oculus Quest 2 headset. Nurses participate in a rhythm-based exergame, Beat Saber, for at least 10 minutes per session, during 8-16 clinical shifts over an 8-week period. The game engages users in physical movement to music, requiring whole-body coordination and providing visual, auditory, and haptic feedback. The intervention aims to reduce stress and anxiety and enhance job performance among ICU nurses by providing an immersive, engaging, and therapeutic experience within the clinical environment.
Time frame: From enrollment to the end of treatment at 8 weeks
Job performance will be assessed using the Turkish version of the Individual Work Performance Scale adapted by Köroğlu Kaba & Öztürk (2021). The 14-item scale includes 3 subscales: Task Performance (5 items), Contextual Performance (6 items), and Counterproductive Work Behavior (3 items, reverse-coded). Items are rated on a 5-point Likert scale from 1 (Rarely) to 5 (Always). Higher scores indicate better performance. The internal consistency of the total scale is reported as 0.80.
Time frame: Before and after each VR session, from enrollment to the end of treatment at 8 weeks
Anxiety levels will be measured using the Spielberger State Anxiety Scale (STAI-State), a validated 20-item self-report questionnaire. The scale evaluates how participants feel at a specific moment, with scores ranging from 20 to 80. Higher scores indicate higher anxiety. The primary analysis will compare pre- and post-intervention scores to evaluate the effect of the immersive virtual reality (IVR) application on anxiety reduction among ICU nurses.
Time frame: From enrollment to the end of treatment at 8 weeks
Anxiety levels will be assessed using the Turkish version of the Spielberger State Anxiety Scale (STAI-State), a 20-item self-report scale that measures how the participant feels in a specific moment. Each item is scored from 1 (Not at all) to 4 (Very much so), with total scores ranging from 20 to 80. Higher scores indicate greater anxiety. The scale has high internal consistency (KR-20: 0.94-0.96). It will be administered on the first and last day of the intervention.
Istanbul University - Cerrahpasa
Other
Effects on Anxiety, Stress, and Work Performance of Intensive Care Nurses Using an Immersive Virtual Reality Application
Acronym: VR-ICU Nurse S
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06022783
Nurse, Stress
Edirne, Turkey, Turkey (Türkiye)
View Trial DetailsNCT05679726
Fatigue, Neurologic Manifestations
Kars, Turkey (Türkiye)
View Trial DetailsNCT05393219
Behavior, Behavioral Symptoms
Lyon, France
View Trial DetailsNCT02982239
Anxiety, Anxiety Disorders
View Trial Details